<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37522762</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>20</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Human herpesvirus 8 ORF57 protein is able to reduce TDP-43 pathology: network analysis identifies interacting pathways.</ArticleTitle><Pagination><StartPage>2966</StartPage><EndPage>2980</EndPage><MedlinePgn>2966-2980</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddad122</ELocationID><Abstract><AbstractText>Aggregation of TAR DNA-binding protein 43&#xa0;kDa (TDP-43) is thought to drive the pathophysiology of amyotrophic lateral sclerosis and some frontotemporal dementias. TDP-43 is normally a nuclear protein that in neurons translocates to the cytoplasm and can form insoluble aggregates upon activation of the integrated stress response (ISR). Viruses evolved to control the ISR. In the case of Herpesvirus 8, the protein ORF57 acts to bind protein kinase R, inhibit phosphorylation of eIF2&#x3b1; and reduce activation of the ISR. We hypothesized that ORF57 might also possess the ability to inhibit aggregation of TDP-43. ORF57 was expressed in the neuronal SH-SY5Y line and its effects on TDP-43 aggregation characterized. We report that ORF57 inhibits TDP-43 aggregation by 55% and elicits a 2.45-fold increase in the rate of dispersion of existing TDP-43 granules. These changes were associated with a 50% decrease in cell death. Proteomic studies were carried out to identify the protein interaction network of ORF57. We observed that ORF57 directly binds to TDP-43 as well as interacts with many components of the ISR, including elements of the proteostasis machinery known to reduce TDP-43 aggregation. We propose that viral proteins designed to inhibit a chronic ISR can be engineered to remove aggregated proteins and dampen a chronic ISR.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Webber</LastName><ForeName>Chelsea J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Departments of Pharmacology, Physiology and Biophysics, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Caroline N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Departments of Pharmacology, Physiology and Biophysics, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rond&#xf3;n-Ortiz</LastName><ForeName>Alejandro N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Departments of Pharmacology, Physiology and Biophysics, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Network Systems Biology, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Spek</LastName><ForeName>Sophie J F</ForeName><Initials>SJF</Initials><AffiliationInfo><Affiliation>Departments of Pharmacology, Physiology and Biophysics, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Elena X</ForeName><Initials>EX</Initials><AffiliationInfo><Affiliation>Departments of Pharmacology, Physiology and Biophysics, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lampl</LastName><ForeName>Noah M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Center for Network Systems Biology, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiesa</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Biological Design Center, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Ahmad S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Biological Design Center, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emili</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Network Systems Biology, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Boston University, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Oregon Health Sciences University, Portland, OR 97239, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolozin</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-2068-1475</Identifier><AffiliationInfo><Affiliation>Departments of Pharmacology, Physiology and Biophysics, Boston University, Boston, MA 02215, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Systems Neuroscience, Boston University, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurophotonics, Boston University, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Boston University, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 EB029483</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG080810</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598480">ORF57 protein, human herpesvirus 8</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054334">Viral Regulatory and Accessory Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019288" MajorTopicYN="Y">Herpesvirus 8, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="Y">Neuroblastoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054334" MajorTopicYN="N">Viral Regulatory and Accessory Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>9</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37522762</ArticleId><ArticleId IdType="pmc">PMC10549787</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddad122</ArticleId><ArticleId IdType="pii">7234031</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M. &#xa0;et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz, L.M., Kwong, L.K., Xu, Y., Truax, A.C., Uryu, K., Neumann, M., Clark, C.M., Elman, L.B., Miller, B.L., Grossman, M. &#xa0;et al. (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol., 173, 182&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou, C.C., Zhang, Y., Umoh, M.E., Vaughan, S.W., Lorenzini, I., Liu, F., Sayegh, M., Donlin-Asp, P.G., Chen, Y.H., Duong, D.M. &#xa0;et al. (2018) TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci., 21, 228&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y.R., King, O.D., Shorter, J. and Gitler, A.D. (2013) Stress granules as crucibles of ALS pathogenesis. J. Cell Biol., 201, 361&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa, F., Lu, S., Yu, H., Chen, C., Melamed, Z., Guo, L., Shorter, J., Da Cruz, S. and Cleveland, D.W. (2019) Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron, 102, 339&#x2013;357.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann, J.R., Gleixner, A.M., Mauna, J.C., Gomes, E., DeChellis-Marks, M.R., Needham, P.G., Copley, K.E., Hurtle, B., Portz, B., Pyles, N.J. &#xa0;et al. (2019) RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron, 102, 321&#x2013;338 e328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling, J.P., Pletnikova, O., Troncoso, J.C. and Wong, P.C. (2015) TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science, 349, 650&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, X.R., Prudencio, M., Koike, Y., Vatsavayai, S.C., Kim, G., Harbinski, F., Briner, A., Rodriguez, C.M., Guo, C., Akiyama, T. &#xa0;et al. (2022) TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature, 603, 124&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, A.L., Wilkins, O.G., Keuss, M.J., Hill, S.E., Zanovello, M., Lee, W.C., Bampton, A., Lee, F.C.Y., Masino, L., Qi, Y.A. &#xa0;et al. (2022) TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature, 603, 131&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong, Y.H., Ling, J.P., Lin, S.Z., Donde, A.N., Braunstein, K.E., Majounie, E., Traynor, B.J., LaClair, K.D., Lloyd, T.E. and Wong, P.C. (2017) Tdp-43 cryptic exons are highly variable between cell types. Mol. Neurodegener., 12, 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5289002</ArticleId><ArticleId IdType="pubmed">28153034</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio, M., Humphrey, J., Pickles, S., Brown, A.L., Hill, S.E., Kachergus, J.M., Shi, J., Heckman, M.G., Spiegel, M.R., Cook, C. &#xa0;et al. (2020) Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Invest., 130, 6080&#x2013;6092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed, Z., Lopez-Erauskin, J., Baughn, M.W., Zhang, O., Drenner, K., Sun, Y., Freyermuth, F., McMahon, M.A., Beccari, M.S., Artates, J.W. &#xa0;et al. (2019) Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci., 22, 180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen, F., Anderton, R.S., Mastaglia, F.L., Flynn, L.L., Winter, S.J., James, I., Bedlack, R., Hodgetts, S., Fletcher, S., Wilton, S.D. &#xa0;et al. (2021) Novel STMN2 variant linked to amyotrophic lateral sclerosis risk and clinical phenotype. Front. Aging Neurosci., 13, 658226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8033025</ArticleId><ArticleId IdType="pubmed">33841129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, H., Lu, S., Gasior, K., Singh, D., Vazquez-Sanchez, S., Tapia, O., Toprani, D., Beccari, M.S., Yates, J.R., 3rd, Da Cruz, S. &#xa0;et al. (2021) HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells. Science, 371, eabb4309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286096</ArticleId><ArticleId IdType="pubmed">33335017</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou, C.C., Alexeeva, O.M., Yamada, S., Pribadi, A., Zhang, Y., Mo, B., Williams, K.R., Zarnescu, D.C. and Rossoll, W. (2015) PABPN1 suppresses TDP-43 toxicity in ALS disease models. Hum. Mol. Genet., 24, 5154&#x2013;5173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4550816</ArticleId><ArticleId IdType="pubmed">26130692</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, L., Kim, H.J., Wang, H., Monaghan, J., Freyermuth, F., Sung, J.C., O'Donovan, K., Fare, C.M., Diaz, Z., Singh, N. &#xa0;et al. (2018) Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell, 173, 677&#x2013;692 e620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H.J., Raphael, A.R., LaDow, E.S., McGurk, L., Weber, R.A., Trojanowski, J.Q., Lee, V.M., Finkbeiner, S., Gitler, A.D. and Bonini, N.M. (2014) Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet., 46, 152&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadge, G.D., Sonobe, Y., Camarena, A., Drigotas, C., Rigo, F., Ling, K.K. and Roos, R.P. (2020) Knockdown of GADD34 in neonatal mutant SOD1 mice ameliorates ALS. Neurobiol. Dis., 136, 104702.</Citation><ArticleIdList><ArticleId IdType="pubmed">31837419</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin, B. and Ivanov, P. (2019) Stress granules and neurodegeneration. Nat. Rev. Neurosci., 20, 649&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wek, S.A., Zhu, S. and Wek, R.C. (1995) The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids. Mol. Cell. Biol., 15, 4497&#x2013;4506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230689</ArticleId><ArticleId IdType="pubmed">7623840</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwen, E., Kedersha, N., Song, B., Scheuner, D., Gilks, N., Han, A., Chen, J.J., Anderson, P. and Kaufman, R.J. (2005) Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. J. Biol. Chem., 280, 16925&#x2013;16933.</Citation><ArticleIdList><ArticleId IdType="pubmed">15684421</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding, H.P., Zhang, Y., Bertolotti, A., Zeng, H. and Ron, D. (2000) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell, 5, 897&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">10882126</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava, S.P., Kumar, K.U. and Kaufman, R.J. (1998) Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J. Biol. Chem., 273, 2416&#x2013;2423.</Citation><ArticleIdList><ArticleId IdType="pubmed">9442091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu, T., Guo, S., Bardhi, O., Ryskamp, D.A., Li, J., Khoramian Tusi, S., Engelbrecht, A., Klippel, K., Chakrabarty, P., Nguyen, L. &#xa0;et al. (2020) Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice. Proc. Natl. Acad. Sci. U. S. A., 117, 18591&#x2013;18599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414156</ArticleId><ArticleId IdType="pubmed">32690681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes, D. and Mallucci, G.R. (2019) The unfolded protein response in neurodegenerative disorders - therapeutic modulation of the PERK pathway. FEBS J., 286, 342&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">29476642</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRocca, T.J., Mariani, A., Watkins, L.R. and Link, C.D. (2019) TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes. Neurobiol. Dis., 132, 104514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834892</ArticleId><ArticleId IdType="pubmed">31229690</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H.M., Wang, L. and D'Mello, S.R. (2008) A chemical compound commonly used to inhibit PKR, 8-(imidazol-4-ylmethylene)-6H-azolidino[5,4-g] benzothiazol-7-one, protects neurons by inhibiting cyclin-dependent kinase. Eur. J. Neurosci., 28, 2003&#x2013;2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3320856</ArticleId><ArticleId IdType="pubmed">19046382</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, Q., Zhao, B., Gui, J., Katlinski, K.V., Brice, A., Gao, Y., Li, C., Kushner, J.A., Koumenis, C., Diehl, J.A. &#xa0;et al. (2015) Type I interferons mediate pancreatic toxicities of PERK inhibition. Proc. Natl. Acad. Sci. U. S. A., 112, 15420&#x2013;15425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4687574</ArticleId><ArticleId IdType="pubmed">26627716</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackrel, M.E., DeSantis, M.E., Martinez, B.A., Castellano, L.M., Stewart, R.M., Caldwell, K.A., Caldwell, G.A. and Shorter, J. (2014) Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell, 156, 170&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3909490</ArticleId><ArticleId IdType="pubmed">24439375</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackrel, M.E., Yee, K., Tariq, A., Chen, A.I. and Shorter, J. (2015) Disparate mutations confer therapeutic gain of Hsp104 function. ACS Chem. Biol., 10, 2672&#x2013;2679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684741</ArticleId><ArticleId IdType="pubmed">26441009</ArticleId></ArticleIdList></Reference><Reference><Citation>March, Z.M., Sweeney, K., Kim, H., Yan, X., Castellano, L.M., Jackrel, M.E., Lin, J., Chuang, E., Gomes, E., Willicott, C.W. &#xa0;et al. (2020) Therapeutic genetic variation revealed in diverse Hsp104 homologs. elife, 9, e57457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785292</ArticleId><ArticleId IdType="pubmed">33319748</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter, J. (2017) Designer protein disaggregases to counter neurodegenerative disease. Curr. Opin. Genet. Dev., 44, 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5447488</ArticleId><ArticleId IdType="pubmed">28208059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, N.R., Majerciak, V., Kruhlak, M.J. and Zheng, Z.M. (2017) KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation. PLoS Pathog., 13, e1006677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5679657</ArticleId><ArticleId IdType="pubmed">29084250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, N.R., Majerciak, V., Kruhlak, M.J., Yu, L., Kang, J.G., Yang, A., Gu, S., Fritzler, M.J. and Zheng, Z.M. (2019) KSHV RNA-binding protein ORF57 inhibits P-body formation to promote viral multiplication by interaction with Ago2 and GW182. Nucleic Acids Res., 47, 9368&#x2013;9385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6755100</ArticleId><ArticleId IdType="pubmed">31400113</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirshner, J.R., Lukac, D.M., Chang, J. and Ganem, D. (2000) Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J. Virol., 74, 3586&#x2013;3597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC111868</ArticleId><ArticleId IdType="pubmed">10729134</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M. and Moore, P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266, 1865&#x2013;1869.</Citation><ArticleIdList><ArticleId IdType="pubmed">7997879</ArticleId></ArticleIdList></Reference><Reference><Citation>Majerciak, V., Yamanegi, K., Nie, S.H. and Zheng, Z.M. (2006) Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J. Biol. Chem., 281, 28365&#x2013;28378.</Citation><ArticleIdList><ArticleId IdType="pubmed">16829516</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, F., Gao, Z.Q., Majerciak, V., Bai, L., Hu, M.L., Lin, X.X., Zheng, Z.M., Dong, Y.H. and Lan, K. (2018) The crystal structure of KSHV ORF57 reveals dimeric active sites important for protein stability and function. PLoS Pathog., 14, e1007232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105031</ArticleId><ArticleId IdType="pubmed">30096191</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, Z. and Swaminathan, S. (2006) Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J. Virol., 80, 5251&#x2013;5260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1472138</ArticleId><ArticleId IdType="pubmed">16699005</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, A.K., Spiller, K.J., Ge, G., Zheng, A., Xu, Y., Zhou, M., Tripathy, K., Kwong, L.K., Trojanowski, J.Q. and Lee, V.M. (2015) Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol., 130, 643&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Klickstein, J.A., Mukkavalli, S. and Raman, M. (2020) AggreCount: an unbiased image analysis tool for identifying and quantifying cellular aggregates in a spatially defined manner. J. Biol. Chem., 295, 17672&#x2013;17683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7762942</ArticleId><ArticleId IdType="pubmed">33454006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi, M. and Brown, R.H., Jr. (2018) Genetics of amyotrophic lateral sclerosis. Cold Spring Harbor perspectives in medicine, 8, a024125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin, B. (2019) The evolution of phase-separated TDP-43 in stress. Neuron, 102, 265&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6816464</ArticleId><ArticleId IdType="pubmed">30998893</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz, L., Bilgutay, A., Zhang, Y.J., Vanderweyde, T., Citro, A., Mehta, T., Zaarur, N., McKee, A., Bowser, R., Sherman, M. &#xa0;et al. (2010) Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One, 5, e13250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourhaghighi, R., Ash, P.E.A., Phanse, S., Goebels, F., Hu, L.Z.M., Chen, S., Zhang, Y., Wierbowski, S.D., Boudeau, S., Moutaoufik, M.T. &#xa0;et al. (2020) BraInMap elucidates the macromolecular connectivity landscape of mammalian brain. Cell Syst, 11, 208.</Citation><ArticleIdList><ArticleId IdType="pubmed">32853540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto, F., Yan, J., Vemula, S.P., Liu, E., Yang, Y., Chen, W., Zheng, J.G., Shi, Y., Siddique, N., Arrat, H. &#xa0;et al. (2011) SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol., 68, 1440&#x2013;1446.</Citation><ArticleIdList><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, Y., Jonson, P.H., Sarparanta, J., Palmio, J., Sarkar, M., Vihola, A., Evila, A., Suominen, T., Penttila, S., Savarese, M. &#xa0;et al. (2018) TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations. J. Clin. Invest., 128, 1164&#x2013;1177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5824866</ArticleId><ArticleId IdType="pubmed">29457785</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu, Z., Pontifex, C.S., Berini, S., Hamilton, L.E., Naddaf, E., Wieben, E., Aleff, R.A., Martens, K., Gruber, A., Engel, A.G. &#xa0;et al. (2018) Myopathy with SQSTM1 and TIA1 variants: clinical and pathological features. Front. Neurol., 9, 147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5868303</ArticleId><ArticleId IdType="pubmed">29599744</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiv, S., Clausen, T.H., Lamark, T., Brech, A., Bruun, J.A., Outzen, H., Overvatn, A., Bjorkoy, G. and Johansen, T. (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem., 282, 24131&#x2013;24145.</Citation><ArticleIdList><ArticleId IdType="pubmed">17580304</ArticleId></ArticleIdList></Reference><Reference><Citation>van der &#xa0;Zee, J., Van Langenhove, T., Kovacs, G.G., Dillen, L., Deschamps, W., Engelborghs, S., Matej, R., Vandenbulcke, M., Sieben, A., Dermaut, B. &#xa0;et al. (2014) Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol., 128, 397&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4131163</ArticleId><ArticleId IdType="pubmed">24899140</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho, M.A., Strider, J., Carter, D., Taylor-Reinwald, L., Forman, M.S., Goate, A.M. and Cairns, N.J. (2009) VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J. Biol. Chem., 284, 12384&#x2013;12398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673306</ArticleId><ArticleId IdType="pubmed">19237541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, N.C., Tresse, E., Kolaitis, R.M., Molliex, A., Thomas, R.E., Alami, N.H., Wang, B., Joshi, A., Smith, R.B., Ritson, G.P. &#xa0;et al. (2013) VCP is essential for mitochondrial quality control by PINK1/parkin and this function is impaired by VCP mutations. Neuron, 78, 65&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3683300</ArticleId><ArticleId IdType="pubmed">23498974</ArticleId></ArticleIdList></Reference><Reference><Citation>Seguin, S.J., Morelli, F.F., Vinet, J., Amore, D., De Biasi, S., Poletti, A., Rubinsztein, D.C. and Carra, S. (2014) Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly. Cell Death Differ., 21, 1838&#x2013;1851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227144</ArticleId><ArticleId IdType="pubmed">25034784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda, K., Watanabe, T.M., Kang, M.G., Seo, J.K., Rhee, H.W. and Tate, S.I. (2022) Valosin-containing protein (VCP) regulates the stability of fused in sarcoma (FUS) granules in cells by changing ATP concentrations. FEBS Lett., 596, 1412&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pubmed">35445401</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedesco, B., Vendredy, L., Timmerman, V. and Poletti, A. (2023) The chaperone-assisted selective autophagy complex dynamics and dysfunctions. Autophagy, 19, 1619&#x2013;1641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10262806</ArticleId><ArticleId IdType="pubmed">36594740</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarouchlioti, C., Parfitt, D.A., Li, W., Gittings, L.M. and Cheetham, M.E. (2018) DNAJ proteins in neurodegeneration: essential and protective factors. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci., 373, 20160534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5717533</ArticleId><ArticleId IdType="pubmed">29203718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima, R.S., Carrettiero, D.C. and Ferrari, M.F.R. (2022) BAG2 prevents tau hyperphosphorylation and increases p62/SQSTM1 in cell models of neurodegeneration. Mol. Biol. Rep., 49, 7623&#x2013;7635.</Citation><ArticleIdList><ArticleId IdType="pubmed">35612780</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Tortosa, E., Baradaran-Heravi, Y., Dillen, L., Choudhury, N.R., Aguero Rabes, P., Perez-Perez, J., Kocoglu, C., Sainz, M.J., Ruiz Gonzalez, A., Tellez, R. &#xa0;et al. (2022) TRIM25 mutation (p.C168*), coding for an E3 ubiquitin ligase, is a cause of early-onset autosomal dominant dementia with amyloid load and parkinsonism. Alzheimers Dement., 19, 2805&#x2013;2815.</Citation><ArticleIdList><ArticleId IdType="pubmed">36576960</ArticleId></ArticleIdList></Reference><Reference><Citation>Majerciak, V., Yamanegi, K., Allemand, E., Kruhlak, M., Krainer, A.R. and Zheng, Z.M. (2008) Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing. J. Virol., 82, 2792&#x2013;2801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2258979</ArticleId><ArticleId IdType="pubmed">18184716</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarado-Hernandez, B., Ma, Y., Sharma, N.R., Majerciak, V., Lobanov, A., Cam, M., Zhu, J. and Zheng, Z.M. (2022) Protein-RNA Interactome analysis reveals wide Association of Kaposi's sarcoma-associated herpesvirus ORF57 with host noncoding RNAs and Polysomes. J. Virol., 96, e0178221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8826805</ArticleId><ArticleId IdType="pubmed">34787459</ArticleId></ArticleIdList></Reference><Reference><Citation>Massimelli, M.J., Majerciak, V., Kruhlak, M. and Zheng, Z.M. (2013) Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA. J. Virol., 87, 243&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3536381</ArticleId><ArticleId IdType="pubmed">23077296</ArticleId></ArticleIdList></Reference><Reference><Citation>Azpurua, J., El-Karim, E.G., Tranquille, M. and Dubnau, J. (2021) A behavioral screen for mediators of age-dependent TDP-43 neurodegeneration identifies SF2/SRSF1 among a group of potent suppressors in both neurons and glia. PLoS Genet., 17, e1009882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8584670</ArticleId><ArticleId IdType="pubmed">34723963</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng, G., Gu, A., Niu, H., Chen, L., Chen, Y., Zhou, M., Zhang, Y., Liu, J., Cai, L., Liang, D. &#xa0;et al. (2022) Amyotrophic lateral sclerosis (ALS) linked mutation in Ubiquilin 2 affects stress granule assembly via TIA-1. CNS Neurosci Ther, 28, 105&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8673703</ArticleId><ArticleId IdType="pubmed">34750982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, L., Lin, W., Zhang, C., Ash, P.E.A., Verma, M., Kwan, J., van &#xa0;Vliet, E., Yang, Z., Cruz, A.L., Boudeau, S. &#xa0;et al. (2021) Interaction of tau with HNRNPA2B1 and N(6)-methyladenosine RNA mediates the progression of tauopathy. Mol. Cell, 81, 4209&#x2013;4227 e4212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8541906</ArticleId><ArticleId IdType="pubmed">34453888</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, J.O., Pioro, E.P., Boehringer, A., Chia, R., Feit, H., Renton, A.E., Pliner, H.A., Abramzon, Y., Marangi, G., Winborn, B.J. &#xa0;et al. (2014) Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci., 17, 664&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski, T.J., Jr., Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, C.R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E.J., Munsat, T. &#xa0;et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 323, 1205&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P. &#xa0;et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 323, 1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis, J., Hart, M.P., Shorter, J., DeJesus-Hernandez, M., Erion, R., Oristano, R., Liu, A.X., Ramos, D., Jethava, N., Hosangadi, D. &#xa0;et al. (2011) A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl. Acad. Sci. U. S. A., 108, 20881&#x2013;20890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Eimer, W.A., Vijaya Kumar, D.K., Navalpur Shanmugam, N.K., Rodriguez, A.S., Mitchell, T., Washicosky, K.J., Gyorgy, B., Breakefield, X.O., Tanzi, R.E. and Moir, R.D. (2018) Alzheimer's disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron, 99, 56&#x2013;63 e53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075814</ArticleId><ArticleId IdType="pubmed">30001512</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak, M.A., Frost, A.L. and Itzhaki, R.F. (2009) Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J. Alzheimers Dis., 16, 341&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">19221424</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns, D.M., Rouleau, N., Parker, R.N., Walsh, K.G., Gehrke, L. and Kaplan, D.L. (2020) A 3D human brain-like tissue model of herpes-induced Alzheimer's disease. Sci. Adv., 6, eaay8828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202879</ArticleId><ArticleId IdType="pubmed">32494701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak, M.A., Itzhaki, R.F., Shipley, S.J. and Dobson, C.B. (2007) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci. Lett., 429, 95&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">17980964</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran, D.N., Bakx, A., van &#xa0;Dis, V., Aronica, E., Verdijk, R.M. and Ouwendijk, W.J.D. (2022) No evidence of aberrant amyloid beta and phosphorylated tau expression in herpes simplex virus-infected neurons of the trigeminal ganglia and brain. Brain Pathol., 32, e13044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9245940</ArticleId><ArticleId IdType="pubmed">34913212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera, J.R., Rodriguez-Izquierdo, I., Jimenez, J.L. and Munoz-Fernandez, M.A. (2020) Analysis of ALS-related proteins during herpes simplex virus-2 latent infection. J. Neuroinflammation, 17, 371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7722435</ArticleId><ArticleId IdType="pubmed">33287823</ArticleId></ArticleIdList></Reference><Reference><Citation>Arimoto, K., Fukuda, H., Imajoh-Ohmi, S., Saito, H., and Takekawa, M. (2008) Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nature Cell Biology, 10, 1324&#x2013;1332.</Citation><ArticleIdList><ArticleId IdType="pubmed">18836437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama, R.R.K., Ward, C.L., Kaushansky, L.J., Lemay, N., Ishigaki, S., Urano, F., and Bosco, D.A. (2013) FUS/TLS assembles into stress granules and is a prosurvival factor during hyperosmolar stress. Journal of Cellular Physiology, 228, 2222&#x2013;2231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000275</ArticleId><ArticleId IdType="pubmed">23625794</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt, E.K., Clavarino, G., Ceppi, M. and Pierre, P. (2009) SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods, 6, 275&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">19305406</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapsomaniki, M.A., Kotsantis, P., Symeonidou, I.E., Giakoumakis, N.N., Taraviras, S. and Lygerou, Z. (2012) easyFRAP: an interactive, easy-to-use tool for qualitative and quantitative analysis of FRAP data. Bioinformatics, 28, 1800&#x2013;1801.</Citation><ArticleIdList><ArticleId IdType="pubmed">22543368</ArticleId></ArticleIdList></Reference><Reference><Citation>Koulouras, G., Panagopoulos, A., Rapsomaniki, M.A., Giakoumakis, N.N., Taraviras, S. and Lygerou, Z. (2018) EasyFRAP-web: a web-based tool for the analysis of fluorescence recovery after photobleaching data. Nucleic Acids Res., 46, W467&#x2013;W472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030846</ArticleId><ArticleId IdType="pubmed">29901776</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopmans, F., Li, K.W., Klaassen, R.V. and Smit, A.B. (2022) MS-DAP platform for downstream data analysis of label-free proteomics uncovers optimal workflows in benchmark data sets and increased sensitivity in analysis of Alzheimer's biomarker data. J. Proteome Res., 22, 374&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9903323</ArticleId><ArticleId IdType="pubmed">36541440</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsch, E.W., Csordas, A., Sun, Z., Jarnuczak, A., Perez-Riverol, Y., Ternent, T., Campbell, D.S., Bernal-Llinares, M., Okuda, S., Kawano, S. &#xa0;et al. (2017) The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition. Nucleic Acids Res., 45, D1100&#x2013;D1106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210636</ArticleId><ArticleId IdType="pubmed">27924013</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol, Y., Bai, J., Bandla, C., Garcia-Seisdedos, D., Hewapathirana, S., Kamatchinathan, S., Kundu, D.J., Prakash, A., Frericks-Zipper, A., Eisenacher, M. &#xa0;et al. (2022) The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res., 50, D543&#x2013;D552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728295</ArticleId><ArticleId IdType="pubmed">34723319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge, S.X., Jung, D. and Yao, R. (2020) ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics, 36, 2628&#x2013;2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7178415</ArticleId><ArticleId IdType="pubmed">31882993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>